Di Donato M, Cristiani C, Capone M, Garofalo C, Madonna G, Passacatini L
Cell Death Dis. 2025; 16(1):34.
PMID: 39837817
PMC: 11751086.
DOI: 10.1038/s41419-025-07350-4.
Nagashima S, Primadharsini P, Takahashi M, Nishiyama T, Murata K, Okamoto H
Pathogens. 2025; 13(12.
PMID: 39770389
PMC: 11678111.
DOI: 10.3390/pathogens13121130.
Zeng J, Wang C, Ruge F, Ji E, Martin T, Sanders A
Sci Rep. 2024; 14(1):30850.
PMID: 39730634
PMC: 11680852.
DOI: 10.1038/s41598-024-81485-w.
Mudedla S, Lee H, Kim J, Jang S, Doddareddy M, Sanam S
ACS Omega. 2024; 9(29):31946-31956.
PMID: 39072081
PMC: 11270731.
DOI: 10.1021/acsomega.4c03615.
Zuchegna C, Leone S, Romano A, Porcellini A, Messina S
BMC Cancer. 2024; 24(1):77.
PMID: 38225605
PMC: 10789061.
DOI: 10.1186/s12885-023-11758-6.
Navigating the ERK1/2 MAPK Cascade.
Martin-Vega A, Cobb M
Biomolecules. 2023; 13(10).
PMID: 37892237
PMC: 10605237.
DOI: 10.3390/biom13101555.
High In Vitro and In Vivo Activity of BI-847325, a Dual MEK/Aurora Kinase Inhibitor, in Human Solid and Hematologic Cancer Models.
Vuaroqueaux V, Musch A, Peille A, Kelter G, Weichert L, Metz T
Cancer Res Commun. 2023; 3(10):2170-2181.
PMID: 37830744
PMC: 10599287.
DOI: 10.1158/2767-9764.CRC-22-0221.
The dichotomy of regulatory B cells in cancer versus allergic disease.
Dang M, Yu J, Galant-Swafford J, Karam S
Mol Carcinog. 2023; 63(1):11-21.
PMID: 37712547
PMC: 10994235.
DOI: 10.1002/mc.23633.
Protein interaction network analysis of mTOR signaling reveals modular organization.
Wehle D, Bass C, Sulc J, Mirzaa G, Smith S
bioRxiv. 2023; .
PMID: 37577705
PMC: 10418199.
DOI: 10.1101/2023.08.04.552011.
Epidermal injury-induced derepression of key regulator ATML1 in newly exposed cells elicits epidermis regeneration.
Iida H, Mahonen A, Jurgens G, Takada S
Nat Commun. 2023; 14(1):1031.
PMID: 36823419
PMC: 9950045.
DOI: 10.1038/s41467-023-36731-6.
High-Throughput Functional Evaluation of MAP2K1 Variants in Cancer.
Mizuno S, Ikegami M, Koyama T, Sunami K, Ogata D, Kage H
Mol Cancer Ther. 2022; 22(2):227-239.
PMID: 36442478
PMC: 9890140.
DOI: 10.1158/1535-7163.MCT-22-0302.
Inhibiting the activation of MAPK (ERK1/2) in stressed Müller cells prevents photoreceptor degeneration.
Zeng S, Zhang T, Chen Y, Chu-Tan J, Jin K, Lee S
Theranostics. 2022; 12(15):6705-6722.
PMID: 36185611
PMC: 9516241.
DOI: 10.7150/thno.71038.
Sex-Based Differences in Human Neutrophil Chemorepulsion.
Consalvo K, Kirolos S, Sestak C, Gomer R
J Immunol. 2022; 209(2):354-367.
PMID: 35793910
PMC: 9283293.
DOI: 10.4049/jimmunol.2101103.
Connectivity Mapping Using a Novel Loss-of-Function Zebrafish Epilepsy Model as a Powerful Strategy for Anti-epileptic Drug Discovery.
Zhang Y, Heylen L, Partoens M, Mills J, Kaminski R, Godard P
Front Mol Neurosci. 2022; 15:881933.
PMID: 35686059
PMC: 9172968.
DOI: 10.3389/fnmol.2022.881933.
Kinase inhibitors: look beyond the label on the bottle.
Dent P, Poklepovic A, Booth L, Hancock J
Cancer Drug Resist. 2022; 2(4):1032-1043.
PMID: 35582272
PMC: 9019203.
DOI: 10.20517/cdr.2019.80.
Strategies for Improving Photodynamic Therapy Through Pharmacological Modulation of the Immediate Early Stress Response.
de Klerk D, de Keijzer M, Dias L, Heemskerk J, de Haan L, Kleijn T
Methods Mol Biol. 2022; 2451:405-480.
PMID: 35505025
DOI: 10.1007/978-1-0716-2099-1_20.
2-Hydroxyestradiol Overcomes Mesenchymal Stem Cells-Mediated Platinum Chemoresistance in Ovarian Cancer Cells in an ERK-Independent Fashion.
Khamaisi H, Mahmoud H, Mahajna J
Molecules. 2022; 27(3).
PMID: 35164068
PMC: 8839885.
DOI: 10.3390/molecules27030804.
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.
Yarchoan M, Cope L, Ruggieri A, Anders R, Noonan A, Goff L
J Clin Invest. 2021; 131(24).
PMID: 34907910
PMC: 8670844.
DOI: 10.1172/JCI152670.
The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles.
Wiwatchaitawee K, Mekkawy A, Quarterman J, Naguib Y, Ebeid K, Geary S
Drug Deliv Transl Res. 2021; 12(7):1684-1696.
PMID: 34635984
PMC: 8995400.
DOI: 10.1007/s13346-021-01065-7.
Contributions of Sodium-Hydrogen Exchanger 1 and Mitogen-Activated Protein Kinases to Enhanced Retinal Venular Constriction to Endothelin-1 in Diabetes.
Chen Y, Ren Y, Rosa Jr R, Kuo L, Hein T
Diabetes. 2021; 70(10):2353-2363.
PMID: 34353852
PMC: 8576499.
DOI: 10.2337/db20-0889.